© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Clinical question: Is dual antiplatelet therapy (DAPT) non-inferior to intravenous thrombolysis in patients with minor non-disabling acute ischemic stroke? Background: Intravenous thrombolytics are...
Clinical question: Are direct oral anticoagulants (DOACs) acceptable compared to low-molecular-weight heparin (LMWH) for preventing venous thromboembolism (VTE) with a safe bleeding risk in cancer...
Clinical question: Is aspirin as effective as low-molecular-weight heparin (LMWH) for thromboprophylaxis in patients with orthopedic trauma? Background: Studies have outlined the benefits of...
As venous thromboembolism (VTE) became an increasingly recognized cause of death in hospitalized patients, prevention became a high priority for the health care system.1,2 Starting in 2005, the Joint...